Fujifilm, the company you may know as a camera company, has been in the biotech business for a while now, after acquiring Diosynth in 2011. Now about 80% of the Fuji capital is invested in biotech. Fujifilm Diosynth Biotech now functions as a contract development and manufacturing organization (CDMO). We work with biotechs covering many disease modalities spanning monoclonal antibodies, proteins, vaccines, gene therapies and cell therapies. Given the broad space spanned, we would be able to accommodate the skills and career aspirations of a broad and diverse student body. We welcome young scientist and engineers to join our vibrant new site in the greater Boston area and hope to grow and expand the site with you on board.
